Vertex Pharmaceuticals

21 Decision Makers Β· 30 Verified Contacts & Email Format

πŸ“ Boston, MABiotechnologyπŸ—“ Est. 1989πŸ‘₯ 1001–5000 employees

About Vertex Pharmaceuticals

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

Email Format

{first_name}_{last_name}@vrtx.com β€” 64.3%

sarah_smith@vrtx.com

{first_name}.{last_name}@vrtx.com β€” 35.7%

sarah.smith@vrtx.com

Leadership & Decision Makers

Contact details of 21 Vertex Pharmaceuticals decision makers

Gillian

Vice President, Strategic Operations, Regulatory Affairs and Quality LinkedIn
  • Work email

    g@vrtx.com

Reshma Kewalramani

CEO and President LinkedIn
  • Work email

    r****************i@vrtx.com

Javier Coindreau

VP Global Strategy Lead - Medical Affairs LinkedIn
  • Work email

    j**************u@vrtx.com

Uma Raut

Director Global Regulatory Affairs, Cell and Gene Therapy LinkedIn
  • Work email

    u******t@vrtx.com

Michele Bellandi

Vice President International Commercial LinkedIn
  • Work email

    m**************i@vrtx.com

Elena Minichiello

Associate Director, Market Access Strategy and Planning LinkedIn
  • Work email

    e***************o@vrtx.com

Joshua Chen

VP Biostatistics LinkedIn
  • Work email

    j*s@vrtx.com

Mac Johnson

Senior Director, Research, Vertex Pharmaceuticals
  • Work email

    m*********n@vrtx.com

Jeffrey Leiden

Executive Chairman

Nina Devlin

Senior Vice President and Chief Communications Officer

Ludovic Fenaux

Senior Vice President, International Commercial Operations

Megan Krench

Director of BD - External Innovation

Mark Hollison

Procurement and Strategic Sourcing Director

John Gray

Senior Vice President, Genetic Therapies Research

Joshua Boger

Founder

Larry Bock

Founder

Ransi Somaratne MD

Senior Vice President

Kelly Swinney

Senior Vice President

Susan (Susie) Lisa

Senior Vice President

Jonathan Poole

Senior Vice President Finance

Paul Negulescu

Senior Vice President, Research

Team & Specialists

Contact details of 9 Vertex Pharmaceuticals team members

Thomas Carney

Manager (GMP facility focus), Project Management Office, Global Capital Project Management LinkedIn
  • Work email

    t***********y@vrtx.com

Rabah Chibane

Operations Supervisor LinkedIn
  • Work email

    r***********e@vrtx.com

Robin Bean

Site Activation Manager LinkedIn
  • Work email

    r********n@vrtx.com

Mark Yu

Senior Research Associate
  • Work email

    m*****u@vrtx.com

Isaac Vasanthkumar

  • Work email

    i****************r@vrtx.com

Guoxiang Ruan

  • Work email

    g***********n@vrtx.com

Phillip Snyder

  • Work email

    p************r@vrtx.com

Morrey Atkinson

  • Work email

    m*************n@vrtx.com

Brian Goldman

Research Fellow

General Emails

General company emails, e.g. customer support lines

    mediainfo@vrtx.com

    General Inquiries

    cherif_benattia@vrtx.com

    Unclassified inbox

    chambers@vrtx.com

    Unclassified inbox

    gert_devoer@vrtx.com

    Unclassified inbox

    hanyu_zhu@vrtx.com

    Unclassified inbox

    panggao_duan@vrtx.com

    Unclassified inbox

Similar Companies like Vertex Pharmaceuticals

Moderna

modernatx.com
Biotechnology Β· Cambridge, MA Β· Est. 2010 Β· 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology Β· Bothell, Washington, United States Β· Est. 1998 Β· 1001–5000 employees Β· $500M–$1B

HQ: Bothell, Washington, United States

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology Β· Temple City, California, United States Β· Est. 2011 Β· 1001–5000 employees

HQ: Temple City, California, United States

Horizon Pharma

horizontherapeutics.com
Pharmaceuticals Β· Northbrook, Illinois, United States Β· Est. 2005 Β· 1001–5000 employees

HQ: Northbrook, Illinois, United States

KBI Biopharma

kbibiopharma.com
Pharmaceuticals Β· Durham, NC Β· Est. 1996 Β· 1001–5000 employees Β· $500M–$1B

HQ: Durham, NC

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 27/07/2025

617-341-6100

Boston, MA

Legal Name: Vertex Pharmaceuticals, Inc
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Founded Date: 1989
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:VRTX
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: 617-341-6100
Last Investment Activity: Mar 1, 2024
Investments Activity: Mar 1, 2024 Feb 20, 2024 Feb 15, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.